ZANAVIR CA atazanavir 200 mg capsule bottle pack Australia - English - Department of Health (Therapeutic Goods Administration)

zanavir ca atazanavir 200 mg capsule bottle pack

cipla australia pty ltd - atazanavir sulfate, quantity: 227.81 mg (equivalent: atazanavir, qty 200 mg) - capsule, hard - excipient ingredients: lactose monohydrate; crospovidone; magnesium stearate; purified water; titanium dioxide; iron oxide red; gelatin; sodium lauryl sulfate - atazanavir is indicated for the treatment of hiv 1 infection, in combination with other antiretroviral agents. this indication is based on analyses of plasma hiv-1 rna levels and cd4 cell counts from controlled studies (see clinical trials).

ZANAVIR CA atazanavir 200 mg capsule blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

zanavir ca atazanavir 200 mg capsule blister pack

cipla australia pty ltd - atazanavir sulfate, quantity: 227.81 mg (equivalent: atazanavir, qty 200 mg) - capsule, hard - excipient ingredients: lactose monohydrate; crospovidone; magnesium stearate; purified water; titanium dioxide; iron oxide red; gelatin; sodium lauryl sulfate - atazanavir is indicated for the treatment of hiv 1 infection, in combination with other antiretroviral agents. this indication is based on analyses of plasma hiv-1 rna levels and cd4 cell counts from controlled studies (see clinical trials).

ZANAVIR CA atazanavir 150 mg capsule bottle pack Australia - English - Department of Health (Therapeutic Goods Administration)

zanavir ca atazanavir 150 mg capsule bottle pack

cipla australia pty ltd - atazanavir sulfate, quantity: 170.85 mg (equivalent: atazanavir, qty 150 mg) - capsule, hard - excipient ingredients: lactose monohydrate; crospovidone; magnesium stearate; purified water; titanium dioxide; iron oxide red; gelatin; sodium lauryl sulfate - atazanavir is indicated for the treatment of hiv 1 infection, in combination with other antiretroviral agents. this indication is based on analyses of plasma hiv-1 rna levels and cd4 cell counts from controlled studies (see clinical trials).

ZANAVIR CA atazanavir 150 mg capsule blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

zanavir ca atazanavir 150 mg capsule blister pack

cipla australia pty ltd - atazanavir sulfate, quantity: 170.85 mg (equivalent: atazanavir, qty 150 mg) - capsule, hard - excipient ingredients: lactose monohydrate; crospovidone; magnesium stearate; purified water; titanium dioxide; iron oxide red; gelatin; sodium lauryl sulfate - atazanavir is indicated for the treatment of hiv 1 infection, in combination with other antiretroviral agents. this indication is based on analyses of plasma hiv-1 rna levels and cd4 cell counts from controlled studies (see clinical trials).

ATAZANAVIR SULFATE AND RITONAVIR TABLETS 300 MG AND 100 MG 300 MG + 100 MG ORAL SOLID ORDINARY FILM-COATED TABLETS Uganda - English - National Drug Authority

atazanavir sulfate and ritonavir tablets 300 mg and 100 mg 300 mg + 100 mg oral solid ordinary film-coated tablets

lupin limited- - atazanavir sulfate + ritonavir - oral solid ordinary film-coated tablets - 300 mg + 100 mg

Atazanavir Sulfate and Ritonavir Tablets Film-Coated Tablet Kenya - English - Pharmacy and Poisons Board

atazanavir sulfate and ritonavir tablets film-coated tablet

hetero labs ltd 7-2-a2 hetero corporate industrial estates sanath - atazanavir sulfate and ritonavir premix… - film-coated tablet - each film-coated tablet contains 300 mg of… - antivirals for systemic use: protease inhibitors

Atazanavir Mylan European Union - English - EMA (European Medicines Agency)

atazanavir mylan

mylan pharmaceuticals limited - atazanavir (as sulfate) - hiv infections - antivirals for systemic use - atazanavir mylan, co-administered with low dose ritonavir, is indicated for the treatment of hiv 1 infected adults and paediatric patients 6 years of age and older in combination with other antiretroviral medicinal products.based on available virological and clinical data from adult patients, no benefit is expected in patients with strains resistant to multiple protease inhibitors (≥ 4 pi mutations). there are very limited data available from children aged 6 to less than 18 years.the choice of atazanavir mylan in treatment experienced adult and paediatric patients should be based on individual viral resistance testing and the patient’s treatment history.

JAMP ATAZANAVIR CAPSULE Canada - English - Health Canada

jamp atazanavir capsule

jamp pharma corporation - atazanavir (atazanavir sulfate) - capsule - 150mg - atazanavir (atazanavir sulfate) 150mg - hiv protease inhibitors

JAMP ATAZANAVIR CAPSULE Canada - English - Health Canada

jamp atazanavir capsule

jamp pharma corporation - atazanavir (atazanavir sulfate) - capsule - 200mg - atazanavir (atazanavir sulfate) 200mg - hiv protease inhibitors

JAMP ATAZANAVIR CAPSULE Canada - English - Health Canada

jamp atazanavir capsule

jamp pharma corporation - atazanavir (atazanavir sulfate) - capsule - 300mg - atazanavir (atazanavir sulfate) 300mg - hiv protease inhibitors